Top 100 Contractors in NAICS 325414: Biological Product (except Diagnostic) Manufacturing, FY2022

Parent companies by net contract obligations Oct 1, 2021 – Sep 30, 2022 Code page on GovTribe

The top 10 won 58% of FY2022 NAICS 325414 contract dollars

Ranking facts

Contract obligations
$3,829,857,843 Net of deobligations, by contracts coded NAICS 325414
Contractors
168 Parent companies with an obligation
Largest contractor
Pfizer Inc. $3.38 billion, 51.2% of obligations
Data as of

Contract actions from FPDS (SAM.gov). How the rankings work · Download all 100 rows as CSV

Full ranking

Rank Contractor Net obligations Share Trend
1
Pfizer Inc. 2 awardees
$3,376,814,890
Rank history: #1 in FY2021 and not on the FY2023–FY2025 lists; unchanged since FY2021.
2
Modernatx Inc.
$308,495,456
Rank history: #3 in FY2021, #2 in FY2023 and not on the FY2024–FY2025 lists; up 1 since FY2021.
3 $33,185,672
Rank history: #26 in FY2021, #3 in FY2023, #6 in FY2024 and #10 in FY2025; up 23 since FY2021.
4 $27,788,710
Rank history: #4 in FY2021, #1 in FY2023 and not on the FY2024–FY2025 lists; unchanged since FY2021.
5
Valneva 2 awardees, including Valneva Usa, Inc.
$25,957,771
Rank history: #6 in FY2021, #5 in FY2023, #7 in FY2024 and not on the FY2025 list; up 1 since FY2021.
6 $20,552,505
Rank history: #8 in FY2021, #4 in FY2023 and not on the FY2024–FY2025 lists; up 2 since FY2021.
7 $4,705,399
Rank history: #12 in FY2021, #12 in FY2023, #52 in FY2024 and not on the FY2025 list; up 5 since FY2021.
8 $3,562,147
Rank history: #13 in FY2021, #8 in FY2023, #12 in FY2024 and #7 in FY2025; up 5 since FY2021.
9 $2,630,052
Rank history: #17 in FY2021, #6 in FY2023, #24 in FY2024 and not on the FY2025 list; up 8 since FY2021.
10 $2,594,930
Rank history: #18 in FY2021, #11 in FY2023, #13 in FY2024 and #12 in FY2025; up 8 since FY2021.
11 $2,573,460
Rank history: #71 in FY2021 and not on the FY2023–FY2025 lists; up 60 since FY2021.
12 $2,516,554
Rank history: #16 in FY2021, #46 in FY2023, #36 in FY2024 and #75 in FY2025; up 4 since FY2021.
13 $1,789,879
Rank history: #19 in FY2021, #10 in FY2023, #17 in FY2024 and #17 in FY2025; up 6 since FY2021.
14 $1,592,819
Rank history: not on the FY2021 list and not on the FY2023–FY2025 lists; new.
15 $1,176,544
Rank history: #72 in FY2021, #37 in FY2023, #51 in FY2024 and #99 in FY2025; up 57 since FY2021.
16 $1,076,372
Rank history: #24 in FY2021, #14 in FY2023, #18 in FY2024 and #45 in FY2025; up 8 since FY2021.
17 $1,034,345
Rank history: not on the FY2021 list, #19 in FY2023 and not on the FY2024–FY2025 lists; new.
18 $1,012,500
Rank history: #14 in FY2021, #9 in FY2023, not on the FY2024 list and #11 in FY2025; down 4 since FY2021.
19 $1,006,494
Rank history: #25 in FY2021, not on the FY2023 list, #27 in FY2024 and #19 in FY2025; up 6 since FY2021.
20
Miltenyi Biotec, Inc.
$750,000
Rank history: #20 in FY2021 and not on the FY2023–FY2025 lists; unchanged since FY2021.
21 $743,783
Rank history: #47 in FY2021, #17 in FY2023, #40 in FY2024 and not on the FY2025 list; up 26 since FY2021.
22 $717,299
Rank history: #35 in FY2021, #24 in FY2023, #45 in FY2024 and #48 in FY2025; up 13 since FY2021.
23 $713,625
Rank history: #28 in FY2021, #7 in FY2023, #10 in FY2024 and #6 in FY2025; up 5 since FY2021.
24 $700,363
Rank history: #39 in FY2021, #20 in FY2023 and not on the FY2024–FY2025 lists; up 15 since FY2021.
25 $694,387
Rank history: #27 in FY2021, #35 in FY2023, #42 in FY2024 and not on the FY2025 list; up 2 since FY2021.
26 $631,766
Rank history: #9 in FY2021 and not on the FY2023–FY2025 lists; down 17 since FY2021.
27 $543,447
Rank history: #33 in FY2021, #22 in FY2023, not on the FY2024 list and #27 in FY2025; up 6 since FY2021.
28 $500,990
Rank history: not on the FY2021 list and not on the FY2023–FY2025 lists; new.
29
Eurofins Scientific SE Through Eurofins Lancaster Laboratories LLC
$349,604
Rank history: not on the FY2021 list and not on the FY2023–FY2025 lists; new.
30 $316,023
Rank history: #15 in FY2021, #27 in FY2023, #46 in FY2024 and #39 in FY2025; down 15 since FY2021.
31 $296,650
Rank history: not on the FY2021 list, #31 in FY2023, #22 in FY2024 and #50 in FY2025; new.
32 $276,678
Rank history: #88 in FY2021, #48 in FY2023, #23 in FY2024 and #30 in FY2025; up 56 since FY2021.
33 $262,964
Rank history: #60 in FY2021, #18 in FY2023 and not on the FY2024–FY2025 lists; up 27 since FY2021.
34 $258,649
Rank history: #34 in FY2021, #28 in FY2023, #20 in FY2024 and not on the FY2025 list; unchanged since FY2021.
35 $258,207
Rank history: #57 in FY2021, #25 in FY2023, #32 in FY2024 and not on the FY2025 list; up 22 since FY2021.
36 $257,900
Rank history: #44 in FY2021, #36 in FY2023, #33 in FY2024 and not on the FY2025 list; up 8 since FY2021.
37 $249,965
Rank history: not on the FY2021 list, #38 in FY2023, #34 in FY2024 and #38 in FY2025; new.
38 $247,619
Rank history: #52 in FY2021, #65 in FY2023, #38 in FY2024 and #53 in FY2025; up 14 since FY2021.
39 $227,859
Rank history: #41 in FY2021, #42 in FY2023, #54 in FY2024 and #79 in FY2025; up 2 since FY2021.
40 $225,126
Rank history: #23 in FY2021, not on the FY2023 list, #82 in FY2024 and not on the FY2025 list; down 17 since FY2021.
41 $213,840
Rank history: #82 in FY2021 and not on the FY2023–FY2025 lists; up 41 since FY2021.
42 $213,400
Rank history: #56 in FY2021, #34 in FY2023, #35 in FY2024 and #34 in FY2025; up 14 since FY2021.
43 $197,053
Rank history: #43 in FY2021, #78 in FY2023 and not on the FY2024–FY2025 lists; unchanged since FY2021.
44 $193,040
Rank history: #31 in FY2021, #51 in FY2023 and not on the FY2024–FY2025 lists; down 13 since FY2021.
45 $180,303
Rank history: #78 in FY2021, not on the FY2023–FY2024 lists and #90 in FY2025; up 33 since FY2021.
46 $178,140
Rank history: #62 in FY2021, #55 in FY2023, #53 in FY2024 and #51 in FY2025; up 16 since FY2021.
47 $175,000
Rank history: #84 in FY2021 and not on the FY2023–FY2025 lists; up 37 since FY2021.
48 $168,400
Rank history: not on the FY2021 list and not on the FY2023–FY2025 lists; new.
49 $161,359
Rank history: #61 in FY2021, #30 in FY2023, #43 in FY2024 and not on the FY2025 list; up 12 since FY2021.
50
American Type Culture Collection
$160,393
Rank history: #67 in FY2021 and not on the FY2023–FY2025 lists; up 17 since FY2021.
51 $151,200
Rank history: not on the FY2021 list, #74 in FY2023, not on the FY2024 list and #58 in FY2025; new.
52 $130,197
Rank history: #87 in FY2021 and not on the FY2023–FY2025 lists; up 35 since FY2021.
53 $127,465
Rank history: #68 in FY2021, #72 in FY2023, #31 in FY2024 and #49 in FY2025; up 15 since FY2021.
54 $126,580
Rank history: not on the FY2021 list and not on the FY2023–FY2025 lists; new.
55 $124,999
Rank history: #66 in FY2021 and not on the FY2023–FY2025 lists; up 11 since FY2021.
56 $117,564
Rank history: #69 in FY2021, #81 in FY2023, #59 in FY2024 and not on the FY2025 list; up 13 since FY2021.
57 $111,496
Rank history: not on the FY2021 list, #73 in FY2023 and not on the FY2024–FY2025 lists; new.
58 $110,199
Rank history: #63 in FY2021, #61 in FY2023 and not on the FY2024–FY2025 lists; up 5 since FY2021.
59 $102,916
Rank history: not on the FY2021 list and not on the FY2023–FY2025 lists; new.
60 $97,915
Rank history: not on the FY2021 list, #76 in FY2023 and not on the FY2024–FY2025 lists; up 102 since FY2021.
61 $95,421
Rank history: #83 in FY2021, #68 in FY2023 and not on the FY2024–FY2025 lists; up 22 since FY2021.
62 $89,426
Rank history: #85 in FY2021 and not on the FY2023–FY2025 lists; up 23 since FY2021.
63 $89,322
Rank history: #93 in FY2021, #32 in FY2023 and not on the FY2024–FY2025 lists; up 30 since FY2021.
64 $88,664
Rank history: not on the FY2021 list, #33 in FY2023 and not on the FY2024–FY2025 lists; new.
65 $88,293
Rank history: not on the FY2021 list and not on the FY2023–FY2025 lists; new.
66 $86,070
Rank history: #75 in FY2021, #45 in FY2023, #47 in FY2024 and #44 in FY2025; up 9 since FY2021.
67 $80,000
Rank history: #50 in FY2021, #53 in FY2023, #50 in FY2024 and #56 in FY2025; down 17 since FY2021.
68 $77,706
Rank history: not on the FY2021 list, #52 in FY2023, not on the FY2024 list and #42 in FY2025; up 54 since FY2021.
69
Merck KG AUF Aktien 2 awardees, including Sigma-Aldrich, Inc. and EMD Millipore Corp
$74,337
Rank history: #77 in FY2021, #80 in FY2023 and not on the FY2024–FY2025 lists; up 8 since FY2021.
70 $72,535
Rank history: not on the FY2021 list, #96 in FY2023, #83 in FY2024 and #54 in FY2025; new.
71 $72,000
Rank history: not on the FY2021 list and not on the FY2023–FY2025 lists; new.
72 $70,000
Rank history: #92 in FY2021 and not on the FY2023–FY2025 lists; up 20 since FY2021.
73 $68,872
Rank history: not on the FY2021 list and not on the FY2023–FY2025 lists; new.
74 $67,880
Rank history: #95 in FY2021 and not on the FY2023–FY2025 lists; up 21 since FY2021.
75
A B C a M PLC Through Abcam Inc.
$66,004
Rank history: #97 in FY2021, #84 in FY2023 and not on the FY2024–FY2025 lists; up 22 since FY2021.
76 $65,665
Rank history: not on the FY2021 list, not on the FY2023 list, #90 in FY2024 and not on the FY2025 list; new.
77 $63,824
Rank history: not on the FY2021 list and not on the FY2023–FY2025 lists; new.
78 $63,675
Rank history: #99 in FY2021, #85 in FY2023, #100 in FY2024 and not on the FY2025 list; up 21 since FY2021.
79
Glaxosmithkline LLC
$62,952
Rank history: #21 in FY2021, #13 in FY2023, #4 in FY2024 and #3 in FY2025; down 58 since FY2021.
80
Takara Holdings Inc. Through Takara Bio Usa, Inc.
$60,592
Rank history: #79 in FY2021, not on the FY2023 list, #64 in FY2024 and not on the FY2025 list; down 1 since FY2021.
81 $55,553
Rank history: not on the FY2021 list, not on the FY2023–FY2024 lists and #78 in FY2025; up 32 since FY2021.
82 $53,136
Rank history: not on the FY2021 list, #90 in FY2023 and not on the FY2024–FY2025 lists; up 28 since FY2021.
83 $49,924
Rank history: #70 in FY2021 and not on the FY2023–FY2025 lists; down 13 since FY2021.
84 $48,753
Rank history: not on the FY2021 list and not on the FY2023–FY2025 lists; new.
85 $45,943
Rank history: not on the FY2021 list, #71 in FY2023, #62 in FY2024 and not on the FY2025 list; new.
86 $43,467
Rank history: not on the FY2021 list and not on the FY2023–FY2025 lists; new.
87 $40,750
Rank history: not on the FY2021 list and not on the FY2023–FY2025 lists; new.
88 $40,000
Rank history: not on the FY2021 list and not on the FY2023–FY2025 lists; new.
89 $39,863
Rank history: not on the FY2021 list, #95 in FY2023, not on the FY2024 list and #98 in FY2025; up 41 since FY2021.
90
VWR International LLC
$39,500
Rank history: #59 in FY2021 and not on the FY2023–FY2025 lists; down 31 since FY2021.
91 $38,321
Rank history: not on the FY2021 list and not on the FY2023–FY2025 lists; new.
92
Horizon Discovery Biosciences Limited 2 awardees
$37,519
Rank history: #64 in FY2021, #49 in FY2023 and not on the FY2024–FY2025 lists; down 28 since FY2021.
93 $36,738
Rank history: not on the FY2021 list and not on the FY2023–FY2025 lists; new.
94 $36,468
Rank history: #30 in FY2021, #21 in FY2023, #19 in FY2024 and #13 in FY2025; down 64 since FY2021.
95 $35,925
Rank history: not on the FY2021 list, #56 in FY2023, #67 in FY2024 and #62 in FY2025; up 19 since FY2021.
96
JPT Peptide Technologies GMBH
$34,936
Rank history: not on the FY2021 list and not on the FY2023–FY2025 lists; up 47 since FY2021.
97 $31,575
Rank history: not on the FY2021 list and not on the FY2023–FY2025 lists; new.
98 $29,843
Rank history: not on the FY2021 list, #60 in FY2023 and not on the FY2024–FY2025 lists; new.
99 $28,800
Rank history: not on the FY2021 list, not on the FY2023 list, #97 in FY2024 and not on the FY2025 list; new.
100 $28,750
Rank history: not on the FY2021 list, #98 in FY2023 and not on the FY2024–FY2025 lists; new.
Show 75 more

100 of 168 contractors listed here. See the rest on GovTribe.

How this ranking works

  • Source: every contract action FPDS records (as published on SAM.gov) in the period, as GovTribe received it.
  • Amounts are net obligations: what was obligated, less what was deobligated. Shares are of $6.59 billion obligated before deobligations, so they never pass 100%.
  • Parent companies: each action counts under the ultimate parent its award record names, or under the awardee when it names none, so no dollar counts twice. Parents of the same name (Inc., LLC and the like aside) count as one company, since FPDS records a company's parent under more than one UEI over time. GovTribe corrects a few parents and names by hand; see the corrections.
  • Fiscal year 2022 ran Oct 1, 2021 – Sep 30, 2022. The Department of Defense reports its contract actions to FPDS about 90 days late, so a fiscal year is ranked once they're in, in February, and the list doesn't change after.
  • Rank changes compare with FY2021. "New" marks a company outside that period's top 500, and "Returned" one of those that was on an earlier fiscal year's list.
  • Rank lines show each company's rank on every fiscal year's list since FY2021, #1 at the top, on a scale that gives the top of the list more room. A dashed stretch spans years it wasn't on the list. The step from FY2021 takes the color of the rank change beside it.
  • Placeholder recipients FPDS uses when it names no company ("Miscellaneous Foreign Contractors" and the like) aren't ranked.

Quick answers

Who were the top 10 NAICS 325414 contractors in FY2022?

1. Pfizer Inc. ($3.38B), 2. Modernatx Inc. ($308M), 3. Seqirus USA Inc. ($33.2M), 4. Emergent Biosolutions Inc. ($27.8M), 5. Valneva ($26M), 6. Boehringer Ingelheim Corporation ($20.6M), 7. Thermo Electron Corporation ($4.71M), 8. The American National Red Cross ($3.56M), 9. SANOFI ($2.63M), 10. Versiti Blood Health, Inc. ($2.59M).

On GovTribe

Research every contractor on this list

  • Every contract, task order and IDV they hold
  • Their subsidiaries, teammates and competitors
  • Open opportunities they're positioned for
  • Alerts when they win new work